We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

42 hedge funds and large institutions have $47.8M invested in Albireo Pharma Inc in 2013 Q2 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more call options, than puts

Call options by funds: $1.46M | Put options by funds: $1.16M

Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
42
Increased
–
Reduced
–
Closed
–
Calls
$1.46M
Puts
$1.16M
Net Calls
+$304K
Net Calls Change
+$304K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$11.2M +$9.33M +89,678 New
JRJ
2
Jeffrey R. Jay
$7.75M +$6.43M +61,795 New
VM
3
VHCP Management
New York
$6.05M +$5.02M +48,214 New
AWMDMG
4
Austin W. Marxe & David M. Greenhouse
New York
$4.64M +$3.85M +37,013 New
William Blair & Company
5
William Blair & Company
Illinois
$3.21M +$4.27M +41,024 New
Wellington Management Group
6
Wellington Management Group
Massachusetts
$2.31M +$1.92M +18,465 New
Goldman Sachs
7
Goldman Sachs
New York
$2.03M +$1.69M +16,209 New
BC
8
Broadfin Capital
New York
$1.92M +$1.59M +15,326 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.6M +$1.33M +12,777 New
AG
10
Artal Group
Luxembourg
$1.22M +$1.01M +9,691 New
UOC
11
UBS O'Connor
Illinois
$1.13M +$936K +9,000 New
EI
12
EAM Investors
California
$1.12M +$929K +8,925 New
BBA
13
Baker Bros. Advisors
New York
$961K +$797K +7,663 New
KFC
14
Klingenstein Fields & Co
New York
$344K +$285K +2,740 New
Group One Trading
15
Group One Trading
Illinois
$243K +$202K +1,940 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$238K +$198K +1,901 New
DY
17
Dowling & Yahnke
California
$226K +$187K +1,802 New
Morgan Stanley
18
Morgan Stanley
New York
$202K +$168K +1,610 New
BFA
19
BlackRock Fund Advisors
California
$166K +$138K +1,326 New
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$165K +$137K +1,318 New
Renaissance Technologies
21
Renaissance Technologies
New York
$164K +$136K +1,306 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$119K +$99.2K +953 New
TC
23
TFS Capital
Pennsylvania
$112K +$93.2K +896 New
Citadel Advisors
24
Citadel Advisors
Florida
$101K +$83.7K +804 New
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$95K +$78.6K +755 New
1
2

ALBO Hedge Fund Activity: Q2 2013 in Review

42 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2013, worth a combined $47.8M.

Buyers outnumbered sellers: 42 funds opened new ALBO positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

  • 42 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $47.8M of Albireo Pharma Inc stock for Q2 2013.
  • 42 funds opened new Albireo Pharma Inc positions in Q2 2013 and 0 closed out, a net change of +42 holders.

Based on aggregated 13F filings for Q2 2013.